Parallel pathways in RAF-induced senescence and conditions for its reversion
暂无分享,去创建一个
C Mann | J. Thuret | R. Courbeyrette | C. Mann | K. Contrepois | M Jeanblanc | S Ragu | C Gey | K Contrepois | R Courbeyrette | J-Y Thuret | C. Gey | M. Jeanblanc | S. Ragu | Thuret Jy
[1] Simon Tavaré,et al. Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.
[2] Frédérick A. Mallette,et al. oncogene-induced senescence The DNA damage signaling pathway is a critical mediator of , 2007 .
[3] C. Johannessen,et al. A negative feedback signaling network underlies oncogene-induced senescence. , 2006, Cancer cell.
[4] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[5] V. Ferrans,et al. Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.
[6] S. Lowe,et al. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.
[7] M. Serrano,et al. Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.
[8] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[9] A. Cuadrado,et al. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. , 2007, Cancer cell.
[10] G. Ferbeyre,et al. Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence , 2009, Molecular and Cellular Biology.
[11] J. R. Smith,et al. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Sedivy,et al. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. , 1999, Cancer research.
[13] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[14] J. Gil,et al. Epigenetic regulation of the INK4b-ARF-INK4a locus , 2010, Epigenetics.
[15] K. Kohn,et al. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. , 2002, Cancer research.
[16] M. Crescenzi,et al. Critical requirement for cell cycle inhibitors in sustaining nonproliferative states , 2007, The Journal of cell biology.
[17] Rugang Zhang,et al. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. , 2011, Molecular cell.
[18] Aaron Bensimon,et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.
[19] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[20] N. Curtin,et al. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.
[21] F. Ishikawa,et al. Loss of linker histone H1 in cellular senescence , 2006, The Journal of cell biology.
[22] T. Jacks,et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.
[23] Peiqing Sun,et al. The pathways to tumor suppression via route p38. , 2007, Trends in biochemical sciences.
[24] J. Pouysségur,et al. Oxygen, a source of life and stress , 2007, FEBS letters.
[25] P. Buehler,et al. Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin. , 1999, Biochemical pharmacology.
[26] E. Ezan,et al. Ultra-high performance liquid chromatography-mass spectrometry for the fast profiling of histone post-translational modifications. , 2010, Journal of proteome research.
[27] Michael Ruogu Zhang,et al. Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence , 2022 .
[28] Dimitris Kletsas,et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.
[29] H. Saya,et al. Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence , 2006, Nature Cell Biology.
[30] W. Du,et al. Retinoblastoma family genes , 2006, Oncogene.
[31] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[32] Shuang Huang,et al. Sequential Activation of the MEK-Extracellular Signal-Regulated Kinase and MKK3/6-p38 Mitogen-Activated Protein Kinase Pathways Mediates Oncogenic ras-Induced Premature Senescence , 2002, Molecular and Cellular Biology.
[33] R. Weinberg,et al. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence , 2011, Oncogene.
[34] J. Pouysségur,et al. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.
[35] M. Baccarini,et al. Targets of Raf in tumorigenesis. , 2010, Carcinogenesis.
[36] Jiahuai Han,et al. Mitogen‐activated protein kinase p38 defines the common senescence‐signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[37] Gabriella De Vita,et al. p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .
[38] L. Lau,et al. The Matricellular Protein CCN1/CYR61 Induces Fibroblast Senescence and Restricts Fibrosis in Cutaneous Wound Healing , 2010, Nature Cell Biology.
[39] L. Hayflick,et al. The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.
[40] James M. Roberts,et al. Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.
[41] U. Rapp,et al. Ras oncogenes and their downstream targets. , 2007, Biochimica et biophysica acta.
[42] Judith Campisi,et al. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.
[43] J. Shay,et al. Developmental differences in the immortalization of lung fibroblasts by telomerase , 2003, Aging cell.
[44] W. Hahn,et al. Mitogen Stimulation Cooperates with Telomere Shortening To Activate DNA Damage Responses and Senescence Signaling , 2004, Molecular and Cellular Biology.
[45] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[46] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[47] S. Lowe,et al. A Novel Role for High-Mobility Group A Proteins in Cellular Senescence and Heterochromatin Formation , 2006, Cell.
[48] D. Woods,et al. Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.
[49] M. Colombo,et al. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. , 2005, Cancer research.
[50] Robert Gentleman,et al. flowCore: a Bioconductor package for high throughput flow cytometry , 2009, BMC Bioinformatics.
[51] R. White,et al. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo , 2006, Nature Protocols.
[52] F. Ochsenbein,et al. In Vivo Study of the Nucleosome Assembly Functions of ASF1 Histone Chaperones in Human Cells , 2008, Molecular and Cellular Biology.
[53] J. Campisi,et al. Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.